Initial Treatment for Asthma Exacerbations in Adults
The initial treatment for asthma exacerbations in adults should include oxygen therapy, inhaled short-acting beta-2 agonists (SABA) such as albuterol, and systemic corticosteroids as the primary interventions, with ipratropium bromide added for severe exacerbations. 1
Assessment of Severity
Before initiating treatment, quickly assess the severity of the exacerbation:
Severe Exacerbation Features:
- Too breathless to complete sentences in one breath
- Respiratory rate >25 breaths/min
- Heart rate >110 beats/min
- PEF <50% of predicted normal or best 1
Life-Threatening Features:
- PEF <33% of predicted normal or best
- Silent chest, cyanosis, or feeble respiratory effort
- Bradycardia or hypotension
- Exhaustion, confusion, or coma 1
Primary Treatment Components
1. Oxygen Therapy
- Administer oxygen through nasal cannulae or mask
- Maintain oxygen saturation >90% (>95% in pregnant women and patients with heart disease)
- Monitor oxygen saturation until clear response to bronchodilator therapy 1
2. Inhaled Short-Acting Beta-2 Agonists
- Dosing Strategy: Administer albuterol 2.5-5 mg via nebulizer or 4-8 puffs via MDI with spacer every 20 minutes for 3 doses initially 1, 2
- For severe exacerbations (FEV1 or PEF <40% predicted), continuous administration may be more effective than intermittent dosing
- After initial 3 doses, frequency varies according to patient response:
3. Systemic Corticosteroids
- Start early (within first hour) as benefits may not be apparent for 6-12 hours 4
- Oral administration is preferred unless patient is vomiting or too dyspneic:
- Prednisone 30-60 mg orally 1
- If IV route necessary:
- Hydrocortisone 200 mg IV 1
- Continue until lung function returns to patient's personal best 1
- For short courses (up to 2 weeks), tapering is not necessary 1
4. Ipratropium Bromide (for moderate to severe exacerbations)
- Add to beta-agonist therapy to increase bronchodilation
- Dosing: 0.5 mg via nebulizer or 8 puffs via MDI with spacer
- Particularly beneficial in patients with severe airflow obstruction
- Most effective when given in the first hour of treatment 1
Monitoring Response to Treatment
- Measure PEF or FEV1 15-30 minutes after starting treatment and after each subsequent dose
- Monitor oxygen saturation continuously
- For severe exacerbations, consider arterial blood gas measurement
- Reassess symptoms, physical examination findings, and lung function after initial 3 doses of bronchodilator 1
Treatment Modifications Based on Response
Good Response:
- Improvement in symptoms
- PEF >70% of predicted or personal best
- Continue treatment with:
- SABA every 3-4 hours
- Oral corticosteroids for 5-10 days
Incomplete Response:
- Persistent symptoms
- PEF 40-70% of predicted or personal best
- Continue:
- SABA every 60 minutes
- Oral corticosteroids
- Consider adding magnesium sulfate 2g IV over 20 minutes for severe cases 1
Poor Response (Severe Exacerbation):
- Severe symptoms, drowsiness, confusion
- PEF <40% of predicted or personal best
- Intensify treatment:
- Continuous SABA nebulization
- Add ipratropium bromide if not already given
- Consider IV magnesium sulfate
- Evaluate need for mechanical ventilation 1
Common Pitfalls to Avoid
Delayed corticosteroid administration - Give systemic corticosteroids early as benefits take 6-12 hours to appear 4
Underestimating severity - Physician subjective assessments are often inaccurate; rely on objective measures like PEF and oxygen saturation 4
Inappropriate antibiotic use - Reserve antibiotics only for cases with clear evidence of bacterial infection (pneumonia, sinusitis) 1
Sedation - Any form of sedation is contraindicated in asthma exacerbations 1
Inadequate monitoring - Continue monitoring even after initial improvement as some patients may deteriorate
Premature discharge - Ensure patients have been stable on discharge medications for 24 hours and have a clear follow-up plan 5
By following this treatment algorithm, most patients with asthma exacerbations can be effectively managed, reducing the risk of hospitalization and relapse.